OpenAlex
PricingAboutJobs
Log inGet started
Work

CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment

HTML

Year: 2022
Type: review
Source: European Journal of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2022.114884
Authors: Jiachen Wen, Siyuan Wang, Rongxian Guo, Dan Liu
Institutions: Shenyang Pharmaceutical University, Yangzhou University
Language: English

Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: CSF1R inhibitor, colony-stimulating factor 1 receptor, tumor-associated macrophages, receptor tyrosine kinase, tumor microenvironment, small molecule inhibitors, PLX3397, pexidartinib, tenosynovial giant cell tumor, combination therapy, osteoclasts, PI3K signaling, ERK signaling, JNK signaling
SDG: Good health and well-being

Open Access status: closed

Funders: Natural Science Foundation of Liaoning Province, U.S. Food and Drug Administration
Awards: G1180071576, G273227774, G3173912399, G3512951898, G3929212764, G4336382674, G4449770470, G6261977116, G8277072685, G8546942827
OpenAlex ID: W4308346200
FWCI: 3.444
Cites: 177
Cited by: 203
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security